Target intelligence / Profile preview

ribosomal protein L36a pseudogene 39 (RPL36AP39)

Target: RPL36AP39
Molecular classification: Other (Processed pseudogene)[14][16][18]

Overview

RPL36AP39, or ribosomal protein L36a pseudogene 39, is a processed pseudogene derived from the parental RPL36A gene that encodes a component of the 60S large ribosomal subunit in humans[5][9][10][14][16][18]. RPL36AP39 does not encode a functional protein, lacks described biological functions, and is not used as a drug or biomarker target. Its presence in the human genome reflects the frequent creation of ribosomal protein gene pseudogenes, typical for genes encoding highly expressed, essential ribosomal proteins. There is currently no evidence for a functional role or disease association related to this pseudogene[14][16][18].

Other names: RPL36A_17_1112[9]ENSG00000230980[10]processed pseudogene[10]

Beyond the preview

Go deeper on ribosomal protein L36a pseudogene 39 (RPL36AP39).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ribosomal protein L36a pseudogene 39 (RPL36AP39).

Explore the full profile